After cerebral ischemia, GDLM mitigates damage brought on by inflammation and oxidative stress, lessens production of inflammatory mediators like IL-6, IL-8, and CRP, and avoids oxygen radical-induced cell membrane damage, which lowers the rate of neuronal apoptosis. The gene discussed is CRP; the disease is brain ischemia.